Spinocerebellar Degeneration Clinical Trial
Official title:
A Phase III Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Verified date | December 2018 |
Source | Kissei Pharmaceutical Co., Ltd. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to investigate the superiority of KPS-0373 to placebo, and evaluate the safety and pharmacokinetics of KPS-0373 in SCD patients.
Status | Completed |
Enrollment | 374 |
Est. completion date | January 2015 |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | |
Gender | All |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: - Japanese SCD patients with mild to moderate ataxia Exclusion Criteria: - Patients with secondary ataxia - Patients with clinically significant hepatic, renal, or cardiovascular dysfunction |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Kissei Pharmaceutical Co., Ltd. |
Japan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | SARA (Scale for the Assessment and Rating of Ataxia) | The change in the SARA total score at the time of final evaluation | 24 weeks | |
Secondary | SF-8 (QOL) | 24 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02889302 -
An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
|
Phase 3 | |
Completed |
NCT04107740 -
C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration
|
Phase 4 | |
Completed |
NCT01970124 -
A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
|
Phase 3 | |
Completed |
NCT01970137 -
A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
|
Phase 3 | |
Completed |
NCT01970111 -
An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
|
Phase 3 | |
Completed |
NCT01004016 -
A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
|
Phase 2 | |
Completed |
NCT00863538 -
Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
|
Phase 2 |